Emetostop Μάλτα - Αγγλικά - Medicines Authority

emetostop

specifar s.a. 1, 28 octovriou street. ag. varvara 123 51 athens, greece - meclozine hydrochloride - tablet - meclozine hydrochloride 30 mg - antihistamines for systemic use

Finar Μάλτα - Αγγλικά - Medicines Authority

finar

specifar s.a. 1, 28 octovriou street. ag. varvara 123 51 athens, greece - finasteride - film-coated tablet - finasteride 5 mg - urologicals

Ofuxal 10mg, Prolonged Release Tablet Μάλτα - Αγγλικά - Medicines Authority

ofuxal 10mg, prolonged release tablet

specifar s.a. 1, 28 octovriou street. ag. varvara 123 51 athens, greece - alfuzosin hydrochloride - prolonged-release tablet - alfuzosin hydrochloride 10 mg - urologicals

Plavidosa 75mg film-coated Tablets Μάλτα - Αγγλικά - Medicines Authority

plavidosa 75mg film-coated tablets

specifar s.a. 1, 28 octovriou street. ag. varvara 123 51 athens, greece - clopidogrel - film-coated tablet - clopidogrel 75 mg - antithrombotic agents

Tamsol 0.4mg prolonged-release hard capsules Μάλτα - Αγγλικά - Medicines Authority

tamsol 0.4mg prolonged-release hard capsules

specifar s.a. 1, 28 octovriou street. ag. varvara 123 51 athens, greece - tamsulosin hydrochloride - prolonged-release capsule - tamsulosin hydrochloride 0.4 mg - urologicals

Maxolon Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

maxolon

valeant pharmaceuticals new zealand ltd - metoclopramide hydrochloride monohydrate 5 mg/ml;  ;   - solution for injection - 5 mg/ml - active: metoclopramide hydrochloride monohydrate 5 mg/ml     excipient: sodium chloride water for injection

RISPEFAR 1 MG Ισραήλ - Αγγλικά - Ministry of Health

rispefar 1 mg

pharmalogic ltd - risperidone 1 mg - film coated tablets - risperidone - risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperidone was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. risperidone is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. risperidone is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distract